Belite Bio (BLTE) Change in Cash (2021 - 2025)
Belite Bio (BLTE) posted quarterly Change in Cash of $195.9 million for Q4 2025, up 2105.31% year-over-year from $8.9 million in Q4 2024, and up 2105.31% quarter-over-quarter from $8.9 million in Q4 2024.
Powered by 
Analysis
Belite Bio (BLTE) Change in Cash (2021 - 2025) Analysis & Trends
Belite Bio's Change in Cash history runs 2 years deep, the most recent figure standing at $195.9 million for Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Belite Bio | 6.44 Bn | 6.44 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 195.90 Mn |
| Dec 31, 2024 | 8.88 Mn |
| Dec 31, 2021 | -8.27 Mn |